Approval · Notice of Compliance 10306 · 2009
BMD SOLUBLE: Notice of Compliance 10306
Issued June 29, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10306
- Date
- June 29, 2009
- Company
- Alpharma Canada CorporationKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antimicrobial
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BMD SOLUBLE | 02328135 | Dormant |
Medicinal ingredients
- BACITRACIN METHYLENE DISALICYLATE 440 MG per G